Requirement of PI3-kinase activity for the nuclear transport of prolactin in cloned murine T lymphocytes

Stanley M. Belkowski, Jason E. Levine, Michael B. Prystowsky

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The murine T-cell clone, L2, requires both IL2 and PRL to proliferate. Proliferation and selected IL2-driven gene expression are blocked by treatment with rapamycin. Since prolactin translocation to the nucleus is IL2 dependent and required for proliferation, experiments were performed to identify activation pathways that might be involved in nuclear transport and proliferation. L2 cells were stimulated with IL2 in the presence and absence of the mTOR inhibitor rapamycin, PI3-kinase inhibitors (wortmannin. LY294002), the p38 MAP kinase inhibitor SB203580 and the vitamin D analog calcipotriol. The immunosuppressant rapamycin markedly inhibited IL2-induced proliferation and prolactin translocation to the nucleus. Similarly, wortmannin and LY294002 inhibited IL2-induced proliferation and markedly decreased the amount of prolactin transported to the nucleus. SB203580 and calcipotriol partially inhibited IL2-induced proliferation but had no effect on prolactin translocation. None of the inhibitors affected Lucifer Yellow uptake indicating that rapamycin, wortmannin and LY294002 did not inhibit early endosomal formation but rather worked to inhibit prolactin translocation at a later point in the retrograde transport pathway.

Original languageEnglish (US)
Pages (from-to)40-47
Number of pages8
JournalJournal of Neuroimmunology
Volume94
Issue number1-2
DOIs
StatePublished - Feb 1 1999

Fingerprint

Cell Nucleus Active Transport
Phosphatidylinositol 3-Kinases
Prolactin
Interleukin-2
T-Lymphocytes
Sirolimus
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
p38 Mitogen-Activated Protein Kinases
Immunosuppressive Agents
Vitamin D
Clone Cells
Gene Expression
wortmannin

Keywords

  • PI3-kinase
  • Prolactin
  • Rapamycin
  • T-cell activation
  • Wortmannin

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Requirement of PI3-kinase activity for the nuclear transport of prolactin in cloned murine T lymphocytes. / Belkowski, Stanley M.; Levine, Jason E.; Prystowsky, Michael B.

In: Journal of Neuroimmunology, Vol. 94, No. 1-2, 01.02.1999, p. 40-47.

Research output: Contribution to journalArticle

@article{06c5725839b94b17a6c2796b5383fd92,
title = "Requirement of PI3-kinase activity for the nuclear transport of prolactin in cloned murine T lymphocytes",
abstract = "The murine T-cell clone, L2, requires both IL2 and PRL to proliferate. Proliferation and selected IL2-driven gene expression are blocked by treatment with rapamycin. Since prolactin translocation to the nucleus is IL2 dependent and required for proliferation, experiments were performed to identify activation pathways that might be involved in nuclear transport and proliferation. L2 cells were stimulated with IL2 in the presence and absence of the mTOR inhibitor rapamycin, PI3-kinase inhibitors (wortmannin. LY294002), the p38 MAP kinase inhibitor SB203580 and the vitamin D analog calcipotriol. The immunosuppressant rapamycin markedly inhibited IL2-induced proliferation and prolactin translocation to the nucleus. Similarly, wortmannin and LY294002 inhibited IL2-induced proliferation and markedly decreased the amount of prolactin transported to the nucleus. SB203580 and calcipotriol partially inhibited IL2-induced proliferation but had no effect on prolactin translocation. None of the inhibitors affected Lucifer Yellow uptake indicating that rapamycin, wortmannin and LY294002 did not inhibit early endosomal formation but rather worked to inhibit prolactin translocation at a later point in the retrograde transport pathway.",
keywords = "PI3-kinase, Prolactin, Rapamycin, T-cell activation, Wortmannin",
author = "Belkowski, {Stanley M.} and Levine, {Jason E.} and Prystowsky, {Michael B.}",
year = "1999",
month = "2",
day = "1",
doi = "10.1016/S0165-5728(98)00202-1",
language = "English (US)",
volume = "94",
pages = "40--47",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Requirement of PI3-kinase activity for the nuclear transport of prolactin in cloned murine T lymphocytes

AU - Belkowski, Stanley M.

AU - Levine, Jason E.

AU - Prystowsky, Michael B.

PY - 1999/2/1

Y1 - 1999/2/1

N2 - The murine T-cell clone, L2, requires both IL2 and PRL to proliferate. Proliferation and selected IL2-driven gene expression are blocked by treatment with rapamycin. Since prolactin translocation to the nucleus is IL2 dependent and required for proliferation, experiments were performed to identify activation pathways that might be involved in nuclear transport and proliferation. L2 cells were stimulated with IL2 in the presence and absence of the mTOR inhibitor rapamycin, PI3-kinase inhibitors (wortmannin. LY294002), the p38 MAP kinase inhibitor SB203580 and the vitamin D analog calcipotriol. The immunosuppressant rapamycin markedly inhibited IL2-induced proliferation and prolactin translocation to the nucleus. Similarly, wortmannin and LY294002 inhibited IL2-induced proliferation and markedly decreased the amount of prolactin transported to the nucleus. SB203580 and calcipotriol partially inhibited IL2-induced proliferation but had no effect on prolactin translocation. None of the inhibitors affected Lucifer Yellow uptake indicating that rapamycin, wortmannin and LY294002 did not inhibit early endosomal formation but rather worked to inhibit prolactin translocation at a later point in the retrograde transport pathway.

AB - The murine T-cell clone, L2, requires both IL2 and PRL to proliferate. Proliferation and selected IL2-driven gene expression are blocked by treatment with rapamycin. Since prolactin translocation to the nucleus is IL2 dependent and required for proliferation, experiments were performed to identify activation pathways that might be involved in nuclear transport and proliferation. L2 cells were stimulated with IL2 in the presence and absence of the mTOR inhibitor rapamycin, PI3-kinase inhibitors (wortmannin. LY294002), the p38 MAP kinase inhibitor SB203580 and the vitamin D analog calcipotriol. The immunosuppressant rapamycin markedly inhibited IL2-induced proliferation and prolactin translocation to the nucleus. Similarly, wortmannin and LY294002 inhibited IL2-induced proliferation and markedly decreased the amount of prolactin transported to the nucleus. SB203580 and calcipotriol partially inhibited IL2-induced proliferation but had no effect on prolactin translocation. None of the inhibitors affected Lucifer Yellow uptake indicating that rapamycin, wortmannin and LY294002 did not inhibit early endosomal formation but rather worked to inhibit prolactin translocation at a later point in the retrograde transport pathway.

KW - PI3-kinase

KW - Prolactin

KW - Rapamycin

KW - T-cell activation

KW - Wortmannin

UR - http://www.scopus.com/inward/record.url?scp=0033081686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033081686&partnerID=8YFLogxK

U2 - 10.1016/S0165-5728(98)00202-1

DO - 10.1016/S0165-5728(98)00202-1

M3 - Article

C2 - 10376934

AN - SCOPUS:0033081686

VL - 94

SP - 40

EP - 47

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -